RPL3 and colorectal carcinoma: In particular, since we had previously demonstrated that uL3 is a transcriptional repressor of SLC7A11 [11], whose overexpression is associated with a chemoresistant phenotype [40], we became interested in investigating the clinical significance of the correlation between uL3 and SLC7A11 expression in the aforementioned cohort of CRC patients.